Molecular mechanisms of asbestos- and silica-induced lung cancer

Phytopharmaceuticals in Cancer Chemoprevention

Volumn , Issue , 2004, Pages 41-62

  Chen, Fei ^a   Vallyathan, Val ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 66749112087     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (184)

1. Greenlee, R.T., Murray, T., Bolden, S., and Wingo, P.A., Cancer statistics, 2000, CA Cancer J. Clin., 50, 7-33, 2000.
2. Perera, F.P., Environment and cancer: who are susceptible?, Science, 278, 1068-1073, 1997.
3. Doll, R. and Peto, R., The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today, J. Natl. Cancer Inst., 66, 1191-1308, 1981.
4. Manning, C.B., Vallyathan, V., and Mossman, B.T., Diseases caused by asbestos: mechanisms of injury and disease development, Int. Immunopharmacol., 2, 191-200, 2002.
5. Chen, F. and Shi, X., Signaling from toxic metals to NF-kappaB and beyond: not just a matter of reactive oxygen species, Environ. Health Perspect., 110 (Suppl. 5), 807-811, 2002.
6. Saffiotti, U., Lung cancer induction by crystalline silica, Prog. Clin. Biol. Res., 374, 51-69, 1992.
7. Hanahan, D. and Weinberg, R.A., The hallmarks of cancer, Cell, 100, 57-70, 2000.
8. Golub, T.R., Slonim, D.K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J.P., Coller, H., Loh, M.L., Downing, J.R., Caligiuri, M.A., Bloomfield, C.D., and Lander, E.S., Molecular classification of cancer: class discovery and class prediction by gene expression monitoring, Science, 286, 531-537, 1999.
9. Bhattacharjee, A., Richards, W.G., Staunton, J., Li, C., Monti, S., Vasa, P., Ladd, C., Beheshti, J., Bueno, R., Gillette, M., Loda, M., Weber, G., Mark, E.J., Lander, E.S., Wong, W., Johnson, B.E., Golub, T.R., Sugarbaker, D.J., and Meyerson, M., Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses, Proc. Natl. Acad. Sci. USA, 98, 13790-13795, 2001.
10. Garber, M.E., Troyanskaya, O.G., Schluens, K., Petersen, S., Thaesler, Z., Pacyna-Gengelbach, M., van de Rijn, M., Rosen, G.D., Perou, C.M., Whyte, R.I., Altman, R.B., Brown, P.O., Botstein, D., and Petersen, I., Diversity of gene expression in adenocarcinoma of the lung, Proc. Natl. Acad. Sci. USA, 98, 13784-13789, 2001.
11. Perou, C.M., Sorlie, T., Eisen, M.B., van de Rijn, M., Jeffrey, S.S., Rees, C.A., Pollack, J.R., Ross, D.T., Johnsen, H., Akslen, L.A., Fluge, O., Pergamenschikov, A., Williams, C., Zhu, S.X., Lonning, P.E., Borresen-Dale, A.L., Brown, P.O., and Botstein, D., Molecular portraits of human breast tumours, Nature, 406, 747-752, 2000.
12. Shih, C., Padhy, L.C., Murray, M., and Weinberg, R.A., Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts, Nature, 290, 261-264, 1981.
13. Balmain, A. and Pragnell, I.B., Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene, Nature, 303, 72-74, 1983.
14. Renan, M.J., How many mutations are required for tumorigenesis? Implications from human cancer data, Mol. Carcinog., 7, 139-146, 1993.
15. Tomlinson, I., Sasieni, P., and Bodmer, W., How many mutations in a cancer?, Am. J. Pathol., 160, 755-758, 2002.
16. Nyberg, K.A., Michelson, R.J., Putnam, C.W., and Weinert, T.A., Toward maintaining the genome:DNA damage and replication checkpoints, Annu. Rev. Genet., 36, 617-656, 2002.
17. Marnett, L.J., Riggins, J.N., and West, J.D., Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein, J. Clin. Invest., 111, 583-593, 2003.
18. Wei, H. and Frenkel, K., Relationship of oxidative events and DNA oxidation in SENCAR mice to in vivo promoting activity of phorbol ester-type tumor promoters, Carcinogenesis, 14, 1195-1201, 1993.
19. Casadevall, M., da Cruz Fresco, P., and Kortenkamp, A., Chromium(VI)-mediated DNA damage:oxidative pathways resulting in the formation of DNA breaks and abasic sites, Chem. Biol. Interact., 123, 117-132, 1999.
20. Hoeijmakers, J.H., Genome maintenance mechanisms for preventing cancer, Nature, 411, 366-374, 2001.
21. Le Page, F., Kwoh, E.E., Avrutskaya, A., Gentil, A., Leadon, S.A., Sarasin, A., and Cooper, P.K., Transcription-coupled repair of 8-oxoguanine: requirement for XPG, TFIIH, and CSB and implications for Cockayne syndrome, Cell, 101, 159-171, 2000.
22. van Hoffen, A., Venema, J., Meschini, R., van Zeeland, A.A., and Mullenders, L.H., Transcriptioncoupled repair removes both cyclobutane pyrimidine dimers and 6-4 photoproducts with equal efficiency and in a sequential way from transcribed DNA in xeroderma pigmentosum group C fibroblasts, EMBO J., 14, 360-367, 1995.
23. Henning, K.A., Li, L., Iyer, N., McDaniel, L.D., Reagan, M.S., Legerski, R., Schultz, R.A., Stefanini, M., Lehmann, A.R., Mayne, L.V. et al., The Cockayne syndrome group A gene encodes a WD repeat protein that interacts with CSB protein and a subunit of RNA polymerase II TFIIH, Cell, 82, 555-564, 1995.
24. Lee, K.B., Wang, D., Lippard, S.J., and Sharp, P.A., Transcription-coupled and DNA damagedependent ubiquitination of RNA polymerase II in vitro, Proc. Natl. Acad. Sci. USA, 99, 4239-4244, 2002.
25. Svejstrup, J.Q., Mechanisms of transcription-coupled DNA repair, Nat. Rev. Mol. Cell. Biol., 3, 21-29, 2002.
26. Goodman, M.F. and Tippin, B., Sloppier copier DNA polymerases involved in genome repair, Curr. Opin. Genet. Dev., 10, 162-168, 2000.
27. Haracska, L., Prakash, L., and Prakash, S., Role of human DNA polymerase kappa as an extender in translesion synthesis, Proc. Natl. Acad. Sci. USA, 99, 16000-16005, 2002.
28. Lehmann, A.R., Replication of damaged DNA in mammalian cells: new solutions to an old problem, Mutat. Res., 509, 23-34, 2002.
29. Kunkel, T.A. and Bebenek, K., DNA replication fidelity, Annu. Rev. Biochem., 69, 497-529, 2000.
30. Bernstein, C., Bernstein, H., Payne, C.M., and Garewal, H., DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis, Mutat. Res., 511, 145-178, 2002.
31. Broomfield, S., Hryciw, T., and Xiao, W., DNA postreplication repair and mutagenesis in Saccharomyces cerevisiae, Mutat. Res., 486, 167-184, 2001.
32. Kaiser, P., Mansour, H.A., Greeten, T., Auer, B., Schweiger, M., and Schneider, R., The human ubiquitin-conjugating enzyme UbcH1 is involved in the repair of UV-damaged, alkylated and crosslinked DNA, FEBS Lett., 350, 1-4, 1994.
33. Hoege, C., Pfander, B., Moldovan, G.L., Pyrowolakis, G., and Jentsch, S., RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO, Nature, 419, 135-141, 2002.
34. Khanna, K.K. and Jackson, S.P., DNA double-strand breaks: signaling, repair and the cancer connection, Nat. Genet., 27, 247-254, 2001.
35. Abraham, R.T., Cell cycle checkpoint signaling through the ATM and ATR kinases, Genes Dev., 15, 2177-2196, 2001.
36. Wang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S.J., and Qin, J., BASC, a super complex of BRCA1- associated proteins involved in the recognition and repair of aberrant DNA structures, Genes Dev., 14, 927-939, 2000.
37. Woo, R.A., McLure, K.G., Lees-Miller, S.P., Rancourt, D.E., and Lee, P.W., DNA-dependent protein kinase acts upstream of p53 in response to DNA damage, Nature, 394, 700-704, 1998.
38. Shieh, S.Y., Ikeda, M., Taya, Y., and Prives, C., DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2, Cell, 91, 325-334, 1997.
39. Jhappan, C., Yusufzai, T.M., Anderson, S., Anver, M.R., and Merlino, G., The p53 response to DNA damage in vivo is independent of DNA-dependent protein kinase, Mol. Cell. Biol., 20, 4075-4083, 2000.
40. Jaiswal, A.S. and Narayan, S., SN2 DNA-alkylating agent-induced phosphorylation of p53 and activation of p21 gene expression, Mutat. Res., 500, 17-30, 2002.
41. Piwnica-Worms, H., Cell cycle: fools rush in, Nature, 401, 535-537, 1999.
42. Krammer, P.H., CD95‘s deadly mission in the immune system, Nature, 407, 789-795, 2000.
43. Hengartner, M.O., The biochemistry of apoptosis, Nature, 407, 770-776, 2000.
44. Newmeyer, D.D. and Ferguson-Miller, S., Mitochondria: releasing power for life and unleashing the machineries of death, Cell, 112, 481-490, 2003.
45. Earnshaw, W.C., Martins, L.M., and Kaufmann, S.H., Mammalian caspases: structure, activation, substrates, and functions during apoptosis, Annu. Rev. Biochem., 68, 383-424, 1999.
46. Yu, H. and Rohan, T., Role of the insulin-like growth factor family in cancer development and progression, J. Natl. Cancer Inst., 92, 1472-1489, 2000.
47. Maehama, T. and Dixon, J.E., PTEN: a tumour suppressor that functions as a phospholipid phosphatase, Trends Cell. Biol., 9, 125-128, 1999.
48. Wu, L., Timmers, C., Maiti, B., Saavedra, H.I., Sang, L., Chong, G.T., Nuckolls, F., Giangrande, P., Wright, F.A., Field, S.J., Greenberg, M.E., Orkin, S., Nevins, J.R., Robinson, M.L., and Leone, G., The E2F1-3 transcription factors are essential for cellular proliferation, Nature, 414, 457-462, 2001.
49. Weinberg, R.A., The retinoblastoma gene and gene product, Cancer Surv., 12, 43-57, 1992.
50. Helin, K., Lees, J.A., Vidal, M., Dyson, N., Harlow, E., and Fattaey, A., A cDNA encoding a pRBbinding protein with properties of the transcription factor E2F, Cell, 70, 337-350, 1992.
51. Chen, T.T. and Wang, J.Y., Establishment of irreversible growth arrest in myogenic differentiation requires the RB LXCXE-binding function, Mol. Cell. Biol., 20, 5571-5580, 2000.
52. Strobeck, M.W., Knudsen, K.E., Fribourg, A.F., DeCristofaro, M.F., Weissman, B.E., Imbalzano, A.N., and Knudsen, E.S., BRG-1 is required for RB-mediated cell cycle arrest, Proc. Natl. Acad. Sci. USA, 97, 7748-7753, 2000.
53. Nielsen, S.J., Schneider, R., Bauer, U.M., Bannister, A.J., Morrison, A., O’Carroll, D., Firestein, R., Cleary, M., Jenuwein, T., Herrera, R.E., and Kouzarides, T., Rb targets histone H3 methylation and HP1 to promoters, Nature, 412, 561-565, 2001.
54. Johnson, D.G., Schwarz, J.K., Cress, W.D., and Nevins, J.R., Expression of transcription factor E2F1 induces quiescent cells to enter S phase, Nature, 365, 349-352, 1993.
55. Johnson, D.G., Cress, W.D., Jakoi, L., and Nevins, J.R., Oncogenic capacity of the E2F1 gene, Proc. Natl. Acad. Sci. USA, 91, 12823-12827, 1994.
56. Kalma, Y., Marash, L., Lamed, Y., and Ginsberg, D., Expression analysis using DNA microarrays demonstrates that E2F-1 up-regulates expression of DNA replication genes including replication protein A2, Oncogene, 20, 1379-1387, 2001.
57. Muller, H., Bracken, A.P., Vernell, R., Moroni, M.C., Christians, F., Grassilli, E., Prosperini, E., Vigo, E., Oliner, J.D., and Helin, K., E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis, Genes Dev., 15, 267-285, 2001.
58. Polager, S., Kalma, Y., Berkovich, E., and Ginsberg, D., E2Fs up-regulate expression of genes involved in DNA replication, DNA repair and mitosis, Oncogene, 21, 437-446, 2002.
59. Lissy, N.A., Davis, P.K., Irwin, M., Kaelin, W.G., and Dowdy, S.F., A common E2F-1 and p73 pathway mediates cell death induced by TCR activation, Nature, 407, 642-645, 2000.
60. Tanaka, H., Matsumura, I., Ezoe, S., Satoh, Y., Sakamaki, T., Albanese, C., Machii, T., Pestell, R.G., and Kanakura, Y., E2F1 and c-Myc potentiate apoptosis through inhibition of NF-kappaB activity that facilitates MnSOD-mediated ROS elimination, Mol. Cell, 9, 1017-1029, 2002.
61. Phillips, A.C., Ernst, M.K., Bates, S., Rice, N.R., and Vousden, K.H., E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways, Mol. Cell, 4, 771-781, 1999.
62. Vogt, P.K., Fortuitous convergences: the beginnings of JUN, Nat. Rev. Cancer, 2, 465-469, 2002.
63. van Dam, H. and Castellazzi, M., Distinct roles of Jun:Fos and Jun:ATF dimers in oncogenesis, Oncogene, 20, 2453-2464, 2001.
64. Smeal, T., Binetruy, B., Mercola, D.A., Birrer, M., and Karin, M., Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73, Nature, 354, 494-496, 1991.
65. Suzuki, T., Murakami, M., Onai, N., Fukuda, E., Hashimoto, Y., Sonobe, M.H., Kameda, T., Ichinose, M., Miki, K., and Iba, H., Analysis of AP-1 function in cellular transformation pathways, J. Virol., 68, 3527-3535, 1994.
66. Wisdom, R., Johnson, R.S., and Moore, C., c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms, EMBO J., 18, 188-197, 1999.
67. Ivanov, V.N., Bhoumik, A., Krasilnikov, M., Raz, R., Owen-Schaub, L.B., Levy, D., Horvath, C.M., and Ronai, Z., Cooperation between STAT3 and c-jun suppresses Fas transcription, Mol. Cell, 7, 517-528, 2001.
68. Schreiber, M., Kolbus, A., Piu, F., Szabowski, A., Mohle-Steinlein, U., Tian, J., Karin, M., Angel, P., and Wagner, E.F., Control of cell cycle progression by c-Jun is p53 dependent, Genes Dev., 13, 607-619, 1999.
69. Shaulian, E., Schreiber, M., Piu, F., Beeche, M., Wagner, E.F., and Karin, M., The mammalian UV response: c-Jun induction is required for exit from p53-imposed growth arrest, Cell, 103, 897-907, 2000.
70. Jochum, W., Passegue, E., and Wagner, E.F., AP-1 in mouse development and tumorigenesis, Oncogene, 20, 2401-2412, 2001.
71. Bader, A.G., Hartl, M., and Bister, K., Conditional cell transformation by doxycycline-controlled expression of the ASV17 v-jun allele, Virology, 270, 98-110, 2000.
72. Fu, S., Bottoli, I., Goller, M., and Vogt, P.K., Heparin-binding epidermal growth factor-like growth factor, a v-Jun target gene, induces oncogenic transformation, Proc. Natl. Acad. Sci. USA, 96, 5716-5721, 1999.
73. Nakano, H., Shindo, M., Sakon, S., Nishinaka, S., Mihara, M., Yagita, H., and Okumura, K., Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1, Proc. Natl. Acad. Sci. USA, 95, 3537-3542, 1998.
74. Claudio, E., Brown, K., Park, S., Wang, H., and Siebenlist, U., BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells, Nat. Immunol., 3, 958-965, 2002.
75. Yilmaz, Z.B., Weih, D.S., Sivakumar, V., and Weih, F., RelB is required for Peyer’s patch development:differential regulation of p52-RelB by lymphotoxin and TNF, EMBO J., 22, 121-130, 2003.
76. Senftleben, U., Cao, Y., Xiao, G., Greten, F.R., Krahn, G., Bonizzi, G., Chen, Y., Hu, Y., Fong, A., Sun, S.C., and Karin, M., Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway, Science, 293, 1495-1499, 2001.
77. Jaspers, I., Zhang, W., Fraser, A., Samet, J.M., and Reed, W., Hydrogen peroxide has opposing effects on IKK activity and IkappaBalpha breakdown in airway epithelial cells, Am. J. Respir. Cell. Mol. Biol., 24, 769-777, 2001.
78. Yin, Z., Ivanov, V.N., Habelhah, H., Tew, K., and Ronai, Z., Glutathione S-transferase p elicits protection against H2O2-induced cell death via coordinated regulation of stress kinases, Cancer Res., 60, 4053-4057, 2000.
79. Korn, S.H., Wouters, E.F., Vos, N., and Janssen-Heininger, Y.M., Cytokine-induced activation of nuclear factor-kappa B is inhibited by hydrogen peroxide through oxidative inactivation of IkappaB kinase, J. Biol. Chem., 276, 35693-35700, 2001.
80. Storz, P. and Toker, A., Protein kinase D mediates a stress-induced NF-kappaB activation and survival pathway, EMBO J., 22, 109-120, 2003.
81. Chen, F., Castranova, V., Shi, X., and Demers, L.M., New insights into the role of nuclear factorkappaB, a ubiquitous transcription factor in the initiation of diseases, Clin. Chem., 45, 7-17, 1999.
82. Carrasco, D., Rizzo, C.A., Dorfman, K., and Bravo, R., The v-rel oncogene promotes malignant Tcell leukemia/lymphoma in transgenic mice, EMBO J., 15, 3640-3650, 1996.
83. Chen, F., Castranova, V., and Shi, X., New insights into the role of nuclear factor-kappaB in cell growth regulation, Am. J. Pathol., 159, 387-397, 2001.
84. Tang, G., Minemoto, Y., Dibling, B., Purcell, N.H., Li, Z., Karin, M., and Lin, A., Inhibition of JNK activation through NF-kappaB target genes, Nature, 414, 313-317, 2001.
85. De Smaele, E., Zazzeroni, F., Papa, S., Nguyen, D.U., Jin, R., Jones, J., Cong, R., and Franzoso, G., Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling, Nature, 414, 308-313, 2001.
86. Vallyathan, V., Shi, X., and Castranova, V., Reactive oxygen species: their relation to pneumoconiosis and carcinogenesis, Environ. Health Perspect., 106 (Suppl. 5), 1151-1155, 1998.
87. Zhang, Z., Shen, H.M., Zhang, Q.F., and Ong, C.N., Critical role of GSH in silica-induced oxidative stress, cytotoxicity, and genotoxicity in alveolar macrophages, Am. J. Physiol., 277, L743-748, 1999.
88. Schins, R.P., Knaapen, A.M., Cakmak, G.D., Shi, T., Weishaupt, C., and Borm, P.J., Oxidant-induced DNA damage by quartz in alveolar epithelial cells, Mutat. Res., 517, 77-86, 2002.
89. Chen, F., Sun, S.C., Kuh, D.C., Gaydos, L.J., and Demers, L.M., Essential role of NF-kappa B activation in silica-induced inflammatory mediator production in macrophages, Biochem. Biophys. Res. Commun., 214, 985-992, 1995.
90. Kang, J.L., Pack, I.S., Hong, S.M., Lee, H.S., and Castranova, V., Silica induces nuclear factor-kappa B activation through tyrosine phosphorylation of I kappa B-alpha in RAW264.7 macrophages, Toxicol. Appl. Pharmacol., 169, 59-65, 2000.
91. Porter, D.W., Barger, M., Robinson, V.A., Leonard, S.S., Landsittel, D., and Castranova, V., Comparison of low doses of aged and freshly fractured silica on pulmonary inflammation and damage in the rat, Toxicology, 175, 63-71, 2002.
92. Sacks, M., Gordon, J., Bylander, J., Porter, D., Shi, X.L., Castranova, V., Kaczmarczyk, W., Van Dyke, K., and Reasor, M.J., Silica-induced pulmonary inflammation in rats: activation of NF-kappa B and its suppression by dexamethasone, Biochem. Biophys. Res. Commun., 253, 181-184, 1998.
93. Desaki, M., Takizawa, H., Kasama, T., Kobayashi, K., Morita, Y., and Yamamoto, K., Nuclear factorkappa b activation in silica-induced interleukin 8 production by human bronchial epithelial cells, Cytokine, 12, 1257-1260, 2000.
94. Duffin, R., Gilmour, P.S., Schins, R.P., Clouter, A., Guy, K., Brown, D.M., MacNee, W., Borm, P.J., Donaldson, K., and Stone, V., Aluminium lactate treatment of DQ12 quartz inhibits its ability to cause inflammation, chemokine expression, and nuclear factor-kappaB activation, Toxicol. Appl. Pharmacol., 176, 10-17, 2001.
95. Hubbard, A.K., Timblin, C.R., Shukla, A., Rincon, M., and Mossman, B.T., Activation of NF-kappaBdependent gene expression by silica in lungs of luciferase reporter mice, Am. J. Physiol. Lung Cell. Mol. Physiol., 282, L968-975, 2002.
96. Chen, F., Lu, Y., Kuhn, D.C., Maki, M., Shi, X., Sun, S.C., and Demers, L.M., Calpain contributes to silica-induced I kappa B-alpha degradation and nuclear factor-kappa B activation, Arch. Biochem. Biophys., 342, 383-388, 1997.
97. Porter, D.W., Ye, J., Ma, J., Barger, M., Robinson, V.A., Ramsey, D., McLaurin, J., Khan, A., Landsittel, D., Teass, A., and Castranova, V., Time course of pulmonary response of rats to inhalation of crystalline silica: NF-kappa B activation, inflammation, cytokine production, and damage, Inhal. Toxicol., 14, 349-367, 2002.
98. Ghosh, S. and Karin, M., Missing pieces in the NF-kappaB puzzle, Cell, 109 (Suppl.), S81-96, 2002.
99. Schreck, R., Rieber, P., and Baeuerle, P.A., Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1, EMBO J., 10, 2247-2258, 1991.
100. Sarih, M., Souvannavong, V., Brown, S.C., and Adam, A., Silica induces apoptosis in macrophages and the release of interleukin-1 alpha and interleukin-1 beta, J. Leukoc. Biol., 54, 407-413, 1993.
101. Tatrai, E., Adamis, Z., Timar, M., and Ungvary, G., Comparative histopathological and biochemical analysis of early stages of exposure to non-silicogenic aluminium silicate- and strongly silicogenic quartz-dust in rats, Exp. Pathol., 23, 163-171, 1983.
102. Reed, J.C., Apoptosis-regulating proteins as targets for drug discovery, Trends Mol. Med., 7, 314-319, 2001.
103. Fiers, W., Beyaert, R., Declercq, W., and Vandenabeele, P., More than one way to die: apoptosis, necrosis and reactive oxygen damage, Oncogene, 18, 7719-7730, 1999.
104. Lemasters, J.J., V. Necrapoptosis and the mitochondrial permeability transition: shared pathways to necrosis and apoptosis, Am. J. Physiol., 276, G1-6, 1999.
105. Iyer, R., Hamilton, R.F., Li, L., and Holian, A., Silica-induced apoptosis mediated via scavenger receptor in human alveolar macrophages, Toxicol. Appl. Pharmacol., 141, 84-92, 1996.
106. Leigh, J., Wang, H., Bonin, A., Peters, M., and Ruan, X., Silica-induced apoptosis in alveolar and granulomatous cells in vivo, Environ. Health Perspect., 105 (Suppl. 5), 1241-1245, 1997.
107. Srivastava, K.D., Rom, W.N., Jagirdar, J., Yie, T.A., Gordon, T., and Tchou-Wong, K.M., Crucial role of interleukin-1beta and nitric oxide synthase in silica-induced inflammation and apoptosis in mice, Am. J. Respir. Crit. Care Med., 165, 527-533, 2002.
108. Otsuki, T., Sakaguchi, H., Tomokuni, A., Aikoh, T., Matsuki, T., Kawakami, Y., Kusaka, M., Ueki, H., Kita, S., and Ueki, A., Soluble Fas mRNA is dominantly expressed in cases with silicosis, Immunology, 94, 258-262, 1998.
109. Borges, V.M., Falcao, H., Leite-Junior, J.H., Alvim, L., Teixeira, G.P., Russo, M., Nobrega, A.F., Lopes, M.F., Rocco, P.M., Davidson, W.F., Linden, R., Yagita, H., Zin, W.A., and DosReis, G.A., Fas ligand triggers pulmonary silicosis, J. Exp. Med., 194, 155-164, 2001.
110. Bowden, D.H. and Adamson, I.Y., The role of cell injury and the continuing inflammatory response in the generation of silicotic pulmonary fibrosis, J. Pathol., 144, 149-161, 1984.
111. Driscoll, K.E., Maurer, J.K., Lindenschmidt, R.C., Romberger, D., Rennard, S.I., and Crosby, L., Respiratory tract responses to dust: relationships between dust burden, lung injury, alveolar macrophage fibronectin release, and the development of pulmonary fibrosis, Toxicol. Appl. Pharmacol., 106, 88-101, 1990.
112. Scaffidi, P., Misteli, T., and Bianchi, M.E., Release of chromatin protein HMGB1 by necrotic cells triggers inflammation, Nature, 418, 191-195, 2002.
113. Chen, J.J., Sun, Y., and Nabel, G.J., Regulation of the proinflammatory effects of Fas ligand (CD95L), Science, 282, 1714-1717, 1998.
114. Faouzi, S., Burckhardt, B.E., Hanson, J.C., Campe, C.B., Schrum, L.W., Rippe, R.A., and Maher, J.J., Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-kappa B-independent, caspase-3-dependent pathway, J. Biol. Chem., 276, 49077-49082, 2001.
115. Uchimura, E., Kodaira, T., Kurosaka, K., Yang, D., Watanabe, N., and Kobayashi, Y., Interaction of phagocytes with apoptotic cells leads to production of pro-inflammatory cytokines, Biochem. Biophys. Res. Commun., 239, 799-803, 1997.
116. Fadok, V.A., Bratton, D.L., Konowal, A., Freed, P.W., Westcott, J.Y., and Henson, P.M., Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF, J. Clin. Invest., 101, 890-898, 1998.
117. McDonald, P.P., Fadok, V.A., Bratton, D., and Henson, P.M., Transcriptional and translational regulation of inflammatory mediator production by endogenous TGF-beta in macrophages that have ingested apoptotic cells, J. Immunol., 163, 6164-6172, 1999.
118. Wahl, S.M., Orenstein, J.M., and Chen, W., TGF-beta influences the life and death decisions of T lymphocytes, Cytokine Growth Factor Rev., 11, 71-79, 2000.
119. Kuempel, E.D., Tran, C.L., Bailer, A.J., Porter, D.W., Hubbs, A.F., and Castranova, V., Biological and statistical approaches to predicting human lung cancer risk from silica, J. Environ. Pathol. Toxicol. Oncol., 20, 15-32, 2001.
120. Deshpande, A., Narayanan, P.K., and Lehnert, B.E., Silica-induced generation of extracellular factor(s) increases reactive oxygen species in human bronchial epithelial cells, Toxicol Sci., 67, 275-283, 2002.
121. Mossman, B.T. and Churg, A., Mechanisms in the pathogenesis of asbestosis and silicosis, Am. J. Respir. Crit. Care Med., 157, 1666-1680, 1998.
122. Shen, H.M., Zhang, Z., Zhang, Q.F., and Ong, C.N., Reactive oxygen species and caspase activation mediate silica-induced apoptosis in alveolar macrophages, Am. J. Physiol. Lung Cell. Mol. Physiol., 280, L10-17, 2001.
123. Daniel, L.N., Mao, Y., and Saffiotti, U., Oxidative DNA damage by crystalline silica, Free Radical Biol. Med., 14, 463-472, 1993.
124. Chvapil, M., Stankova, L., and Malshet, V., Lipid peroxidation as one of the mechanisms of silica fibrogenicity? I: study with erythrocytes, Environ. Res., 11, 78-88, 1976.
125. Allison, A.C. and Ferluga, J., Cell membranes in cytotoxicity, Adv. Exp. Med. Biol., 84, 231-246, 1977.
126. Shi, X.L., Dalal, N.S., Hu, X.N., and Vallyathan, V., The chemical properties of silica particle surface in relation to silica-cell interactions, J. Toxicol. Environ. Health, 27, 435-454, 1989.
127. Van Dyke, K., Antonini, J.M., Wu, L., Ye, Z., and Reasor, M.J., The inhibition of silica-induced lung inflammation by dexamethasone as measured by bronchoalveolar lavage fluid parameters and peroxynitrite-dependent chemiluminescence, Agents Actions, 41, 44-49, 1994.
128. Blackford, Jr., J.A., Antonini, J.M., Castranova, V., and Dey, R.D., Intratracheal instillation of silica up-regulates inducible nitric oxide synthase gene expression and increases nitric oxide production in alveolar macrophages and neutrophils, Am. J. Respir. Cell. Mol. Biol., 11, 426-431, 1994.
129. Setoguchi, K., Takeya, M., Akaike, T., Suga, M., Hattori, R., Maeda, H., Ando, M., and Takahashi, K., Expression of inducible nitric oxide synthase and its involvement in pulmonary granulomatous inflammation in rats, Am. J. Pathol., 149, 2005-2022, 1996.
130. Schapira, R.M., Wiessner, J.H., Morrisey, J.F., Almagro, U.A., and Nelin, L.D., L-arginine uptake and metabolism by lung macrophages and neutrophils following intratracheal instillation of silica in vivo, Am. J. Respir. Cell. Mol. Biol., 19, 308-315, 1998.
131. Castranova, V., Huffman, L.J., Judy, D.J., Bylander, J.E., Lapp, L.N., Weber, S.L., Blackford, J.A., and Dey, R.D., Enhancement of nitric oxide production by pulmonary cells following silica exposure, Environ. Health Perspect., 106 (Suppl. 5), 1165-1169, 1998.
132. Cunha, F.Q., Assreuy, J., Moncada, S., and Liew, F.Y., Phagocytosis and induction of nitric oxide synthase in murine macrophages, Immunology, 79, 408-411, 1993.
133. Claudio, E., Segade, F., Wrobel, K., Ramos, S., and Lazo, P.S., Activation of murine macrophages by silica particles in vitro is a process independent of silica-induced cell death, Am. J. Respir. Cell. Mol. Biol., 13, 547-554, 1995.
134. Huffman, L.J., Judy, D.J., and Castranova, V., Regulation of nitric oxide production by rat alveolar macrophages in response to silica exposure, J. Toxicol. Environ. Health A, 53, 29-46, 1998.
135. Chen, F., Kuhn, D.C., Sun, S.C., Gaydos, L.J., and Demers, L.M., Dependence and reversal of nitric oxide production on NF-kappa B in silica and lipopolysaccharide-induced macrophages, Biochem. Biophys. Res. Commun., 214, 839-846, 1995.
136. Kang, J.L., Lee, K., and Castranova, V., Nitric oxide up-regulates DNA-binding activity of nuclear factor-kappaB in macrophages stimulated with silica and inflammatory stimulants, Mol. Cell. Biochem., 215, 1-9, 2000.
137. Tweedale, G., Asbestos and its lethal legacy, Nat. Rev. Cancer, 2, 311-315, 2002.
138. Mossman, B.T., Kamp, D.W., and Weitzman, S.A., Mechanisms of carcinogenesis and clinical features of asbestos-associated cancers, Cancer Invest., 14, 466-480, 1996.
139. Ekstrom, A.M., Eriksson, M., Hansson, L.E., Lindgren, A., Signorello, L.B., Nyren, O., and Hardell, L., Occupational exposures and risk of gastric cancer in a population-based case-control study, Cancer Res., 59, 5932-5937, 1999.
140. Rom, W.N., Hammar, S.P., Rusch, V., Dodson, R., and Hoffman, S., Malignant mesothelioma from neighborhood exposure to anthophyllite asbestos, Am. J. Ind. Med., 40, 211-214, 2001.
141. Mossman, B.T., Bignon, J., Corn, M., Seaton, A., and Gee, J.B., Asbestos: scientific developments and implications for public policy, Science, 247, 294-301, 1990.
142. Sincock, A.M., Delhanty, J.D., and Casey, G., A comparison of the cytogenetic response to asbestos and glass fibre in Chinese hamster and human cell lines: demonstration of growth inhibition in primary human fibroblasts, Mutat. Res., 101, 257-268, 1982.
143. Jaurand, M.C., Kheuang, L., Magne, L., and Bignon, J., Chromosomal changes induced by chrysotile fibres or benzo-3,4-pyrene in rat pleural mesothelial cells, Mutat. Res., 169, 141-148, 1986.
144. Dopp, E., Saedler, J., Stopper, H., Weiss, D.G., and Schiffmann, D., Mitotic disturbances and micronucleus induction in Syrian hamster embryo fibroblast cells caused by asbestos fibers, Environ. Health Perspect., 103, 268-271, 1995.
145. Rom, W.N., Livingston, G.K., Casey, K.R., Wood, S.D., Egger, M.J., Chiu, G.L., and Jerominski, L., Sister chromatid exchange frequency in asbestos workers, J. Natl. Cancer Inst., 70, 45-48, 1983.
146. Marczynski, B., Czuppon, A.B., Marek, W., Reichel, G., and Baur, X., Increased incidence of DNA double-strand breaks and anti-ds DNA antibodies in blood of workers occupationally exposed to asbestos, Hum. Exp. Toxicol., 13, 3-9, 1994.
147. Kasai, H. and Nishimura, S., DNA damage induced by asbestos in the presence of hydrogen peroxide, Gann, 75, 841-844, 1984.
148. Fubini, B. and Mollo, L., Role of iron in the reactivity of mineral fibers, Toxicol. Lett., 82-83, 951-960, 1995.
149. Xu, A., Wu, L.J., Santella, R.M., and Hei, T.K., Role of oxyradicals in mutagenicity and DNA damage induced by crocidolite asbestos in mammalian cells, Cancer Res., 59, 5922-5926, 1999.
150. Churg, A. and Stevens, B., Enhanced retention of asbestos fibers in the airways of human smokers, Am. J. Respir. Crit. Care Med., 151, 1409-1413, 1995.
151. Brown, R.C., Fleming, G.T., and Knight, A.I., Asbestos affects the in vitro uptake and detoxification of aromatic compounds, Environ. Health Perspect., 51, 315-318, 1983.
152. Gerde, P. and Scholander, P., Adsorption of benzo(a)pyrene on to asbestos and manmade mineral fibres in an aqueous solution and in a biological model solution, Br. J. Ind. Med., 45, 682-688, 1988.
153. Husgafvel-Pursiainen, K., Hackman, P., Ridanpaa, M., Anttila, S., Karjalainen, A., Partanen, T., Taikina-Aho, O., Heikkila, L., and Vainio, H., K-ras mutations in human adenocarcinoma of the lung:association with smoking and occupational exposure to asbestos, Int. J. Cancer, 53, 250-256, 1993.
154. Wang, X., Christiani, D.C., Wiencke, J.K., Fischbein, M., Xu, X., Cheng, T.J., Mark, E., Wain, J.C., and Kelsey, K.T., Mutations in the p53 gene in lung cancer are associated with cigarette smoking and asbestos exposure, Cancer Epidemiol. Biomarkers Prev., 4, 543-548, 1995.
155. Mishra, A., Liu, J.Y., Brody, A.R., and Morris, G.F., Inhaled asbestos fibers induce p53 expression in the rat lung, Am. J. Respir. Cell. Mol. Biol., 16, 479-485, 1997.
156. Nuorva, K., Makitaro, R., Huhti, E., Kamel, D., Vahakangas, K., Bloigu, R., Soini, Y., and Paakko, P., p53 Protein accumulation in lung carcinomas of patients exposed to asbestos and tobacco smoke, Am. J. Respir. Crit. Care Med., 150, 528-533, 1994.
157. Luo, J.C., Zehab, R., Anttila, S., Ridanpaa, M., Husgafvel-Pursiainen, K., Vainio, H., Carney, W., De Vivo, I., Milling, C., and Brandt-Rauf, P.W., Detection of serum p53 protein in lung cancer patients, J. Occup. Med., 36, 155-160, 1994.
158. Johnson, N.F., Carpenter, T.R., Jaramillo, R.J., and Liberati, T.A., DNA damage-inducible genes as biomarkers for exposures to environmental agents, Environ. Health Perspect., 105 (Suppl. 4), 913-918, 1997.
159. Isik, R., Metintas, M., Gibbs, A.R., Metintas, S., Jasani, B., Oner, U., Harmanci, E., Demircan, S., and Isiksoy, S., p53, p21 and metallothionein immunoreactivities in patients with malignant pleural mesothelioma: correlations with the epidemiological features and prognosis of mesotheliomas with environmental asbestos exposure, Respir. Med., 95, 588-593, 2001.
160. Matsuoka, M., Igisu, H., and Morimoto, Y., Phosphorylation of p53 protein in A549 human pulmonary epithelial cells exposed to asbestos fibers, Environ. Health Perspect., 111, 509-512, 2003.
161. Janssen, Y.M., Barchowsky, A., Treadwell, M., Driscoll, K.E., and Mossman, B.T., Asbestos induces nuclear factor kappa B (NF-kappa B) DNA-binding activity and NF-kappa B-dependent gene expression in tracheal epithelial cells, Proc. Natl. Acad. Sci. USA, 92, 8458-8462, 1995.
162. Simeonova, P.P. and Luster, M.I., Asbestos induction of nuclear transcription factors and interleukin 8 gene regulation, Am. J. Respir. Cell. Mol. Biol., 15, 787-795, 1996.
163. Janssen, Y.M., Driscoll, K.E., Howard, B., Quinlan, T.R., Treadwell, M., Barchowsky, A., and Mossman, B.T., Asbestos causes translocation of p65 protein and increases NF-kappa B DNA binding activity in rat lung epithelial and pleural mesothelial cells, Am. J. Pathol., 151, 389-401, 1997.
164. Faux, S.P. and Howden, P.J., Possible role of lipid peroxidation in the induction of NF, Environ. Health Perspect., 105S, 1127-1130, 1997.
165. Brown, R.C. and Poole, A., Arachidonic acid release and prostaglandin synthesis in a macrophagelike cell line exposed to asbestos, Agents Actions, 15, 336-340, 1984.
166. Camandola, S., Leonarduzzi, G., Musso, T., Varesio, L., Carini, R., Scavazza, A., Chiarpotto, E., Baeuerle, P.A., and Poli, G., Nuclear factor kB is activated by arachidonic acid but not by eicosapentaenoic acid, Biochem. Biophys. Res. Commun., 229, 643-647, 1996.
167. Bonizzi, G., Piette, J., Merville, M.P., and Bours, V., Distinct signal transduction pathways mediate nuclear factor-kappaB induction by IL-1beta in epithelial and lymphoid cells, J. Immunol., 159, 5264-5272, 1997.
168. Zhang, Y., Lee, T.C., Guillemin, B., Yu, M.C., and Rom, W.N., Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure, J. Immunol., 150, 4188-4196, 1993.
169. Simeonova, P.P. and Luster, M.I., Iron and reactive oxygen species in the asbestos-induced tumor necrosis factor-alpha response from alveolar macrophages, Am. J. Respir. Cell. Mol. Biol., 12, 676-683, 1995.
170. Driscoll, K.E., Carter, J.M., Hassenbein, D.G., and Howard, B., Cytokines and particle-induced inflammatory cell recruitment, Environ. Health Perspect., 105 (Suppl. 5), 1159-1164, 1997.
171. Brody, A.R., Liu, J.Y., Brass, D., and Corti, M., Analyzing the genes and peptide growth factors expressed in lung cells in vivo consequent to asbestos exposure and in vitro, Environ. Health Perspect., 105 (Suppl. 5), 1165-1171, 1997.
172. Heintz, N.H., Janssen, Y.M., and Mossman, B.T., Persistent induction of c-fos and c-jun expression by asbestos, Proc. Natl. Acad. Sci. USA, 90, 3299-3303, 1993.
173. Ding, M., Dong, Z., Chen, F., Pack, D., Ma, W.Y., Ye, J., Shi, X., Castranova, V., and Vallyathan, V., Asbestos induces activator protein-1 transactivation in transgenic mice, Cancer Res., 59, 1884-1889, 1999.
174. Fung, H., Quinlan, T.R., Janssen, Y.M., Timblin, C.R., Marsh, J.P., Heintz, N.H., Taatjes, D.J., Vacek, P., Jaken, S., and Mossman, B.T., Inhibition of protein kinase C prevents asbestos-induced c-fos and c-jun proto-oncogene expression in mesothelial cells, Cancer Res., 57, 3101-3105, 1997.
175. Sandhu, H., Dehnen, W., Roller, M., Abel, J., and Unfried, K., mRNA expression patterns in different stages of asbestos-induced carcinogenesis in rats, Carcinogenesis, 21, 1023-1029, 2000.
176. Ramos-Nino, M.E., Timblin, C.R., and Mossman, B.T., Mesothelial cell transformation requires increased AP-1 binding activity and ERK-dependent Fra-1 expression, Cancer Res., 62, 6065-6069, 2002.
177. Zanella, C.L., Posada, J., Tritton, T.R., and Mossman, B.T., Asbestos causes stimulation of the extracellular signal-regulated kinase 1 mitogen-activated protein kinase cascade after phosphorylation of the epidermal growth factor receptor, Cancer Res., 56, 5334-5338, 1996.
178. Zanella, C.L., Timblin, C.R., Cummins, A., Jung, M., Goldberg, J., Raabe, R., Tritton, T.R., and Mossman, B.T., Asbestos-induced phosphorylation of epidermal growth factor receptor is linked to c-fos and apoptosis, Am. J. Physiol., 277, L684-693, 1999.
179. Jimenez, L.A., Zanella, C., Fung, H., Janssen, Y.M., Vacek, P., Charland, C., Goldberg, J., and Mossman, B.T., Role of extracellular signal-regulated protein kinases in apoptosis by asbestos and H2O2, Am. J. Physiol., 273, L1029-1035, 1997.
180. Geist, L.J., Powers, L.S., Monick, M.M., and Hunninghake, G.W., Asbestos stimulation triggers differential cytokine release from human monocytes and alveolar macrophages, Exp. Lung Res., 26, 41-56, 2000.
181. Flaherty, D.M., Monick, M.M., Carter, A.B., Peterson, M.W., and Hunninghake, G.W., Oxidantmediated increases in redox factor-1 nuclear protein and activator protein-1 DNA binding in asbestostreated macrophages, J. Immunol., 168, 5675-5681, 2002.
182. Fung, H., Kow, Y.W., Van Houten, B., Taatjes, D.J., Hatahet, Z., Janssen, Y.M., Vacek, P., Faux, S.P., and Mossman, B.T., Asbestos increases mammalian AP-endonuclease gene expression, protein levels, and enzyme activity in mesothelial cells, Cancer Res., 58, 189-194, 1998.
183. Xanthoudakis, S. and Curran, T., Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity, EMBO J., 11, 653-665, 1992.
184. Abate, C., Patel, L., Rauscher, III, F.J., and Curran, T., Redox regulation of fos and jun DNA-binding activity in vitro, Science, 249, 1157-1161, 1990.